Sinclair Pharma PLC Annual Financial Report (0809B)

TIDMSPH

RNS Number : 0809B

Sinclair Pharma PLC

30 March 2017

Sinclair Pharma plc

Publication of Annual Report and Accounts

London, 30 March 2017 Sinclair Pharma plc (SPH.L), ("Sinclair" or the "Company") the international aesthetics company, announces that its Annual Report and Accounts for the year ended 31 December 2016 is available at the Company's website, www.sinclairpharma.com and will be posted to shareholders shortly.

For further information please contact:

 
 Sinclair Pharma plc    Tel: +44 (0) 
                         20 7467 6920 
 Chris Spooner 
  Alan Olby 
  Andy Crane 
 
 Peel Hunt LLP (NOMAD   Tel: +44 (0) 
  and Joint Broker)      20 7418 8900 
 James Steel 
  Oliver Jackson 
 
 
 RBC Capital Markets    Tel: +44 (0) 
  (Joint Broker)         20 76534000 
 Marcus Jackson 
  Laura White 
 
 
 Media enquiries 
 FTI Consulting         Tel: +44 (0) 
                         203 727 1000 
 Ben Atwell 
  Brett Pollard 
 

Notes to Editors:

About Sinclair Pharma plc

Sinclair Pharma plc is an international company operating in the fast growth, high gross margin, global aesthetics market. Sinclair has built a strong portfolio of differentiated, complementary aesthetics technologies, which are experiencing significant growth, targeting unmet clinical needs for effective, high quality, longer duration, natural looking and minimally-invasive treatments. The Company is planning entry to multiple new geographic markets and line extension launches over the next few years. Sinclair has an established sales and marketing presence in the leading EU markets and Brazil, and a network of international distributors. For more information, please visit www.sinclairpharma.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

ACSOKKDPPBKDNNN

(END) Dow Jones Newswires

March 30, 2017 11:55 ET (15:55 GMT)